Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immune Thrombocytopenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04289207
What this trial is testing

Phase II Trial of Romiplostim With Danazol in Patients With Eltrombopag-resistant Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Seoul National University Hospital 55
Testing effectiveness (Phase 2)Study completedNCT00902018
What this trial is testing

Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Immune Thrombocytopenia
Weill Medical College of Cornell University 20
Testing effectiveness (Phase 2)Study completedNCT00049725
What this trial is testing

Daclizumab to Treat Chronic Immune Thrombocytopenia

Who this might be right for
Thrombocytopenia
National Institutes of Health Clinical Center (CC) 24
Testing effectiveness (Phase 2)Looking for participantsNCT07017725
What this trial is testing

A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia

Who this might be right for
Chronic Immune Thrombocytopenia
CASI pharmaceuticals, Inc. 75
Testing effectiveness (Phase 2)Looking for participantsNCT06352281
What this trial is testing

Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP)

Who this might be right for
ITP - Immune Thrombocytopenia
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 10
Testing effectiveness (Phase 2)Looking for participantsNCT06992128
What this trial is testing

Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 129
Early research (Phase 1)Looking for participantsNCT06826430
What this trial is testing

Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia

Who this might be right for
Autoimmune Thrombocytopenia
Juventas Cell Therapy Ltd. 12
Early research (Phase 1)Ended earlyNCT02009761
What this trial is testing

Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP).

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Boehringer Ingelheim 6
Post-approval studies (Phase 4)Not Yet RecruitingNCT07189910
What this trial is testing

Sequential rhTPO and Eltrombopag Following Glucocorticoids for Severe Adult ITP

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 150
Testing effectiveness (Phase 2)Study completedNCT03664518
What this trial is testing

To Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV Infection

Who this might be right for
Thrombocytopenia PurpuraChronic HBV Infection
Institute of Hematology & Blood Diseases Hospital, China 48
Not applicableLooking for participantsNCT06479291
What this trial is testing

The Efficacy and Safety of HCQ Plus TPO-RA in ANA Positive ITP

Who this might be right for
Immune Thrombocytopenia With Positive ANA Antibodies
Yunfeng Cheng 126
Testing effectiveness (Phase 2)Study completedNCT03830749
What this trial is testing

Safety and Efficacy of Eltrombopag Plus Pulsed Dexamethasone for Subjects With Idiopathic Thrombocytopenic Purpura

Who this might be right for
Immune Thrombocytopenia
Humanity & Health Medical Group Limited 53
Not applicableLooking for participantsNCT04528355
What this trial is testing

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+2 more
Paul Szabolcs 50
Testing effectiveness (Phase 2)Looking for participantsNCT01962415
What this trial is testing

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more
Paul Szabolcs 100
Large-scale testing (Phase 3)Ended earlyNCT01433978
What this trial is testing

A Phase 3, Multicenter, Randomized, Double-blind,Active-controlled, Parallel-group Trial With an Open-labelExtension Phase to Evaluate the Efficacy and Safety of OralE5501 Versus Eltrombopag, in Adults With Chronic ImmuneThrombocytopenia (Idiopathic Thrombocytopenic Purpura)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Eisai Inc. 24
Testing effectiveness (Phase 2)Looking for participantsNCT05070845
What this trial is testing

Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Pfizer 91
Large-scale testing (Phase 3)WithdrawnNCT05046327
What this trial is testing

Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of ≤6 Months

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT03333486
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Leukemia in RemissionAcute Lymphoblastic Leukemia+34 more
Roswell Park Cancer Institute 31
Early research (Phase 1)Not Yet RecruitingNCT07574073
What this trial is testing

CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related Cytopenia

Who this might be right for
Anti-CD20 Monoclonal AntibodyBTK InhibitorsImmune Thrombocytopenia (ITP)+1 more
Qi deng 30
Early research (Phase 1)Not Yet RecruitingNCT07622329
What this trial is testing

A Clinical Study to Evaluate JCXH-213 in the Treatment of Adults With Primary Immune Thrombocytopenia

Who this might be right for
Thrombocytopenic Purpura, Immune
The General Hospital of Western Theater Command 4
Next Page